1. Home
  2. LDI vs TKNO Comparison

LDI vs TKNO Comparison

Compare LDI & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo loanDepot Inc.

LDI

loanDepot Inc.

N/A

Current Price

$0.89

Market Cap

542.4M

Sector

Finance

ML Signal

N/A

Logo Alpha Teknova Inc.

TKNO

Alpha Teknova Inc.

HOLD

Current Price

$7.41

Market Cap

268.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LDI
TKNO
Founded
2010
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
542.4M
268.1M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
LDI
TKNO
Price
$0.89
$7.41
Analyst Decision
Sell
Analyst Count
3
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
2.8M
245.3K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.86
EPS
N/A
N/A
Revenue
N/A
$40,520,000.00
Revenue This Year
$17.58
$8.27
Revenue Next Year
$13.99
$13.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.35
52 Week Low
$0.83
$1.91
52 Week High
$5.05
$7.84

Technical Indicators

Market Signals
Indicator
LDI
TKNO
Relative Strength Index (RSI) 40.42 68.29
Support Level $0.83 $3.79
Resistance Level $1.32 $7.84
Average True Range (ATR) 0.07 0.64
MACD 0.00 0.06
Stochastic Oscillator 17.44 83.35

Price Performance

Historical Comparison
LDI
TKNO

About LDI loanDepot Inc.

loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.

About TKNO Alpha Teknova Inc.

Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.

Share on Social Networks: